Recent Company News

• 08:00 PM ET Jul 11, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 08:59 AM ET Jul 09, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 05:04 PM ET Jul 09, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:48 PM ET Jul 08, 2025
  

  Telix Pharmaceuticals' Gozellix granted HCPCS code by the CMS (A$24.03, -0.01)

• 06:12 AM ET Jul 03, 2025
  

  Telix Pharmaceuticals initiated buy at HC Wainwright ($16.50, 0.00)

• 09:45 PM ET Jul 02, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 11:18 PM ET Jun 24, 2025
  

  Telix Pharmaceuticals' Illuccix receives marketing approval in Portugal (A$24.04, -0.36)

• 07:21 AM ET Jun 23, 2025
  

  Telix Pharmaceuticals's Illuccix obtains US FDA approval for patient selection for pre-Taxane RLT (A$24.48, 0.00)

• 08:02 AM ET Jun 20, 2025
  

  Telix Pharmaceuticals announces AlFluor radiochemistry platform (A$24.92, 0.00)